Tirzepatide has emerged as a groundbreaking therapy for type 2 diabetes, offering promising results. However, the price of this innovative drug and its availability have become key topics for patients and healthcare professionals. While tirzepatide has been cleared by regulatory agencies, its high-priced nature presents a significant challenge to